Literature DB >> 25175558

Levels and complexity of IgA antibody against oral bacteria in samples of human colostrum.

L N Petrechen1, F H Zago2, M L T Sesso3, B B Bertoldo4, C B Silva5, K P Azevedo6, S A de Lima Pereira7, V R Geraldo-Martins8, V P L Ferriani9, R D Nogueira10.   

Abstract

Streptococcus mutans (SM) have three main virulence antigens: glucan binding protein B (gbpB), glucosyltransferase (Gtf) and antigens I/II (Ag I/II) envolved in the capacity of those bacteria to adhere and accumulate in the dental biofilm. Also, the glycosyltransferases 153 kDa of Streptococcus gordonii (SGO) and 170kDa of Streptococcus sanguinis (SSA) were important antigens associated with the accumulation of those bacterias. Streptococcus mitis (SMI) present IgA1 protease of 202 kDa. We investigated the specificity and levels IgA against those antigens of virulence in samples of human colostrum. This study involved 77 samples of colostrum that were analyzed for levels of immunoglobulian A, M and G by Elisa. The specificity of IgA against extracts of SM and initials colonizators (SSA, SMI, SGO) were analyzed by the Western blot. The mean concentration of IgA was 2850.2 (±2567.2) mg/100 mL followed by IgM and IgG (respectively 321.8±90.3 and 88.3±51.5), statistically different (p<0.05). Results showed that the majority of samples had detectable levels of IgA antibodies to extracts of bacteria antigens and theirs virulence antigens. To SM, the GbpB was significantly lower detected than others antigens of SM (p<0.05). High complexities of response to Ags were identified in the samples. There were no significant differences in the mean number of IgA-reactive Ags between the antigens (p>0.4). So, the breast milk from first hours after birth presented significant levels of IgA specific against important virulence of antigens those oral streptococci, which can disrupt the installation and accumulation process of these microorganisms in the oral cavity.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Colostrum; IgA; Mucosal immunity; Streptococcus mutans

Mesh:

Substances:

Year:  2014        PMID: 25175558     DOI: 10.1016/j.imbio.2014.08.009

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  5 in total

1.  Streptococcus mutans in Umbilical Cord Blood, Peripheral Blood, and Saliva from Healthy Mothers.

Authors:  Marcelly Milhomem Mendes; Camilla Beatriz da Silva; Denise Bertulucci Rocha Rodrigues; Barbara Rocha Rodrigues; Vinicius Rangel Geraldo-Martins; Virginia Paes Leme Ferriani; Virmondes Rodrigues; Ruchele Dias Nogueira
Journal:  Curr Microbiol       Date:  2018-06-22       Impact factor: 2.188

2.  Analysis of colostrum IgA against bacteria involved in neonatal infections.

Authors:  Elizabeth Moreira Dias; Denise Bertulucci Rocha Rodrigues; Vinícius Rangel Geraldo-Martins; Ruchele Dias Nogueira
Journal:  Einstein (Sao Paulo)       Date:  2017 Jul-Sep

3.  Streptococcus mutans detection in saliva and colostrum samples.

Authors:  Camilla Beatriz da Silva; Marcelly Milhomem Mendes; Bárbara Rocha Rodrigues; Thiago Lima Pereira; Denise Bertulucci Rocha Rodrigues; Virmondes Rodrigues Junior; Virginia Paes Leme Ferriani; Vinicius Rangel Geraldo-Martins; Ruchele Dias Nogueira
Journal:  Einstein (Sao Paulo)       Date:  2019-01-31

4.  Infectious episodes during pregnancy, at particular mucosal sites, increase specific IgA1 or IgA2 subtype levels in human colostrum.

Authors:  Erick Sánchez-Salguero; Geovanni Kaleb Mondragón-Ramírez; Julio C Alcántara-Montiel; Arturo Cérbulo-Vázquez; Xóchitl Villegas-Domínguez; Víctor Manuel Contreras-Vargas; María Del Rocío Thompson-Bonilla; Héctor Romero-Ramírez; Leopoldo Santos-Argumedo
Journal:  Matern Health Neonatol Perinatol       Date:  2019-06-11

Review 5.  The Breast Milk Immunoglobulinome.

Authors:  Karla Rio-Aige; Ignasi Azagra-Boronat; Margarida Castell; Marta Selma-Royo; María Carmen Collado; María J Rodríguez-Lagunas; Francisco J Pérez-Cano
Journal:  Nutrients       Date:  2021-05-26       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.